Cargando…
Co-treatment with Vactosertib, a Novel, Orally Bioavailable Activin Receptor-like Kinase 5 Inhibitor, Suppresses Radiotherapy-induced Epithelial-to-mesenchymal Transition, Cancer Cell Stemness, and Lung Metastasis of Breast Cancer
BACKGROUND: Acquired metastasis and invasion of cancer cells during radiotherapy are in part due to induction of epithelial-to-mesenchymal transition (EMT) and cancer stem cell (CSC) properties, which are mediated by TGF-β signaling. Here we evaluated the anti-metastatic therapeutic potential of vac...
Autores principales: | Choi, Jiwon, Park, Jiyoung, Cho, Ilyoung, Sheen, Yhunyhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122287/ https://www.ncbi.nlm.nih.gov/pubmed/35390248 http://dx.doi.org/10.2478/raon-2022-0012 |
Ejemplares similares
-
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
por: Park, Jiyoung, et al.
Publicado: (2022) -
Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease
por: Song, Kang-Moon, et al.
Publicado: (2020) -
Activin-A signaling promotes epithelial–mesenchymal transition, invasion, and metastatic growth of breast cancer
por: Bashir, Mohsin, et al.
Publicado: (2015) -
Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011) -
Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)